Equity Analysis /
United States of America

US : Mirum Pharmaceuticals, Inc. - MIRM | 1Q21 Update: Expansion into China and Possible Foray into Gene Therapy

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    9 May 2021
    Published by